Effect of testosterone on insulin sensitivity, oxidative metabolism, and body‐composition in aging men with type 2 diabetes on metformin monotherapy

ConclusionTRT of aging men with lowered BioT‐levels and T2D controlled on metformin monotherapy improved body‐composition; however glycemic control, peripheral insulin‐sensitivity, EGP and substrate metabolism were unchanged.Clinical trial registration number: NCT01560546, www.clinicaltrials.gov

Source: Diabetes, Obesity and Metabolism - May 31, 2016 Category: Endocrinology Authors: L.V. Magnussen, D. Glintborg, P. Hermann, D.M. Hougaard, K. Højlund, M. Andersen Tags: ORIGINAL ARTICLE Source Type: research